| Autor: |
Petrogiannis, Nikos, Chatzovoulou, Kalliopi, Filippa, Maria, Grimbizis, Grigoris, Kolibianakis, Efstratios, Chatzimeletiou, Katerina |
| Předmět: |
|
| Zdroj: |
Zygote; Jun2024, Vol. 32 Issue 3, p183-189, 7p |
| Abstrakt: |
Summary: In vitro maturation of oocytes (IVM) represents an assisted reproductive technique that involves the minimal or absence of ovarian stimulation and is beneficial to specific groups of patients. These may include women with polycystic ovarian syndrome and/or patients who need a fertility preservation option before undergoing gonadotoxic treatment. However, when IVM is applied in cases where it is not recommended, it can be considered as an add-on technique, as described by the ESHRE Guideline Group on Female Fertility Preservation. Interestingly, IVM has not been proven yet to be as effective as conventional IVF in the laboratory, in terms of clinical pregnancy and live birth rates, while concerns have been raised for its long-term safety. As a result, both safety and efficacy of IVM remain still questionable and additional data are needed to draw conclusions. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
